div class=ts-pagebutton class=gotoPage data-page=1Page 1button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page1jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=1 data-page=1 class=ts-thumb lazyload alt=Page 1: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails1jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=2Page 2button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page2jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=2 data-page=2 class=ts-thumb lazyload alt=Page 2: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails2jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=3Page 3button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page3jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=3 data-page=3 class=ts-thumb lazyload alt=Page 3: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails3jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=4Page 4button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page4jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=4 data-page=4 class=ts-thumb lazyload alt=Page 4: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails4jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=5Page 5button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page5jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=5 data-page=5 class=ts-thumb lazyload alt=Page 5: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails5jpg width=140 height=200 adivdivdiv class=ts-pagebutton class=gotoPage data-page=6Page 6button div class=ts-imagea href=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5page6jpg target=_blank img data-url=-considerados-en-el-informe-presentado-por-el-sub-comite-de-homologacion-htmlpage=6 data-page=6 class=ts-thumb lazyload alt=Page 6: promesecalgobdopromesecalgobdowp-contentuploads201807Acta-de-Adjudicacion · considerados en el Informe presentado por el Sub-Comité de Homologación Lorazepam Multivitaminas loading=lazy src=data:imagegifbase64iVBORw0KGgoAAAANSUhEUgAAAAIAAAACCAQAAADYv8WvAAAAD0lEQVR42mP8X8AwAgiABKBAv+vAXklAAAAAElFTkSuQmCC data-src=https:reader039vdocumentscoreader039viewer20220312065bc1dd3c09d3f27d2f8bce38html5thumbnails6jpg width=140 height=200 adivdiv
